9 research outputs found

    Additional file 1: Table S1. of Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study

    No full text
    a) Observed group mean values (± SD) for α-synuclein at inclusion (baseline), and after one and two years, and b) predicted mean value (95 % CI) at baseline, together with estimated mean change (95 % CI) from baseline values.1 (DOCX 14 kb

    Clinical characteristics of the Norwegian myasthenia gravis study cohort (n = 369).

    No full text
    1<p>According to MGFA classification <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0036603#pone.0036603-JaretzkiA1" target="_blank">[39]</a>: ocular MG (MGFA grade I), generalised MG (MGFA grade II-V), not available in 12 cases.</p>2<p>Concomitant immune-mediated diseases include thyroid disease (hypo-, hyperthyroidsm, thyroiditis), type 1-diabetes, rheumatic diseases, systemic lupus erythematosus (SLE), celiac disease, inflammatory bowel diseases (CrohƄs disease or ulcerative colitits). EOMG = early onset MG; LOMG = late onset MG; AChR-ab+  =  acetylcholine receptor-antibody positive.</p

    Schematic overview of associated HLA alleles in MG.

    No full text
    <p>The HLA complex on chromosome 6 with its division into three classes. Some key genes and their order on the chromosome are given. Associated HLA alleles reported earlier in Caucasian MG patients (see text for complete references) are illustrated together with the results from the present study.</p
    corecore